Is CHELF or MRK a better dividend investment in 2026?

CHELF currently yields 46511.63% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CHELF offers higher current income.

What is the dividend yield difference between CHELF and MRK?

CHELF has a forward dividend yield of 46511.63% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 46508.87 percentage points.

Home › Compare › CHELF vs MRK

CHELF vs MRK: Dividend Comparison 2026

CHELF yields 46511.63% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHELF wins by $2.3287701923887015e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHELF

● Live price

46511.63%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.3287701923887015e+23M

Annual income

$231,896,242,969,289,280,000,000,000,000.00

Full CHELF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CHELF vs MRK

📍 CHELF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHELF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHELF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHELF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHELF

Annual income on $10K today (after 15% tax)

$3,953,488.37/yr

After 10yr DRIP, annual income (after tax)

$197,111,806,523,895,900,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CHELF beats the other by $197,111,806,523,895,900,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHELF + MRK for your $10,000?

CHELF: 50%MRK: 50%

100% MRK50/50100% CHELF

Portfolio after 10yr

$1.1643850961943508e+23M

Annual income

$115,948,121,484,644,640,000,000,000,000.00/yr

Blended yield

99.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CHELF

No analyst data

Altman Z

-61.9

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHELF buys

MRK buys

No recent congressional trades found for CHELF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHELFMRK

Forward yield	46511.63% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$2.3287701923887015e+23M	$56.8K ✓
Annual income after 10y	$231,896,242,969,289,280,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$2.328126193995221e+23M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CHELF vs MRK ($10,000, DRIP)

Year	CHELF Portfolio	CHELF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$4,661,863	$4,651,162.79	$11,206	$366.19	+$4.65M → CHELF
2	$2,031,444,525	$2,026,456,331.54	$12,650	$502.35	+$2031.43M → CHELF
3	$827,449,144,353	$825,275,498,711.84	$14,407	$694.19	+$827449.13M → CHELF
4	$315,045,826,291,782	$314,160,455,707,324.25	$16,585	$967.82	+$315045826.28M → CHELF
5	$112,126,379,245,088,940	$111,789,280,210,956,740.00	$19,342	$1,363.89	+$112126379245.07M → CHELF
6	$37,303,490,926,858,680,000	$37,183,515,701,066,430,000.00	$22,913	$1,947.19	+$37303490926858.66M → CHELF
7	$11,601,259,433,115,970,000,000	$11,561,344,697,824,233,000,000.00	$27,662	$2,823.89	+$11601259433115970.00M → CHELF
8	$3,372,730,239,458,152,600,000,000	$3,360,316,891,864,719,000,000,000.00	$34,159	$4,173.35	+$3372730239458152448.00M → CHELF
9	$916,613,336,056,902,100,000,000,000	$913,004,514,700,681,900,000,000,000.00	$43,337	$6,308.80	+$916613336056902057984.00M → CHELF
10	$232,877,019,238,870,140,000,000,000,000	$231,896,242,969,289,280,000,000,000,000.00	$56,776	$9,798.13	+$2.3287701923887015e+23M → CHELF

CHELF vs MRK: Complete Analysis 2026

CHELF — Stock

Champion Electric Metals Inc., a discovery-focused exploration company, engages in the acquisition and exploration of natural resources in Canada and the United States. It explores for lithium and cobalt deposits. The company holds a 100% interest in the Champion Electric lithium project that comprises of 980 claims covering an area of approximately 500.66 square kilometers located in Quebec, Canada. It also holds interest in the Idaho cobalt project that owns 622 claims covering an area of approximately 6,871 hectares located in northern Idaho. The company was formerly known as Idaho Champion Gold Mines Canada Inc. and changed its name to Champion Electric Metals Inc. in May 2023. Champion Electric Metals Inc. is based in Toronto, Canada.

Full CHELF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CHELF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHELF vs SCHD CHELF vs JEPI CHELF vs O CHELF vs KO CHELF vs MAIN CHELF vs JNJ CHELF vs ABBV CHELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.